The White House FY 2020 budget proposal
The Administration has been active in outlining its agenda to lower prescription drug costs. In May 2018, the Administration published its American Patients First Blueprint, which outlined the Administration’s proposals to reduce drug costs. The FY 2020 budget proposal builds off of these concepts, proposals in previous budget requests, and current Administration action relating to prescription drug pricing by making additional, sometimes new, proposals to modernize Medicaid and Medicare Parts B and D.
We note, there were no specific regulatory proposals included in the budget on prescription drug pricing. Instead the budget focuses on legislative proposals relating to prescription drug pricing.
Click here to read our HHS-wide proposal analysis.